Elevance Health (ELV)

SG&A Expenses

$5.75B

Quarterly · Period ending: · USD

ELV logo

ELV SG&A Expenses

Latest reported$5.75B
ELV Quarterly SG&A Expenses ($2.25B → $5.75B)
High-resolution chart · PNG

ELV sg&a expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Elevance Health SG&A Expenses — Quarterly (USD)
Period endingSG&A Expenses (USD)
5,752,000,000
0
6,330,000,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,969,100,000
3,200,200,000
3,268,400,000
3,080,400,000
3,040,800,000
3,145,200,000
3,032,800,000
2,968,300,000
2,885,800,000
2,861,500,000
2,537,400,000
2,542,700,000
2,435,600,000
2,329,100,000
2,412,200,000
2,078,600,000
2,081,800,000
2,165,700,000
2,228,400,000
2,119,600,000
2,011,100,000
2,076,500,000
2,367,300,000
2,063,200,000
2,154,700,000
2,174,100,000
2,553,600,000
2,260,300,000
2,205,900,000
2,228,900,000
2,333,100,000
2,220,200,000
2,218,600,000
2,248,600,000
2,119,700,000
2,189,900,000
2,260,300,000
2,131,600,000
2,254,300,000
2,198,700,000
2,192,100,000
2,172,600,000
1,862,900,000
1,847,800,000
1,832,900,000
1,729,100,000
1,100,200,000
782,600,000
789,700,000
765,000,000
835,800,000
783,500,000
773,900,000
716,400,000
772,900,000
683,700,000
544,400,000
505,600,000
520,200,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.